| Patents for A61P 13 - Drugs for disorders of the urinary system (56,135) |
|---|
| 01/09/1997 | WO1997000884A1 Meiosis regulating compounds |
| 01/09/1997 | WO1997000691A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | CA2225401A1 Modulation of endothelial cell proliferation |
| 01/09/1997 | CA2224866A1 Meiosis regulating compounds |
| 01/09/1997 | CA2224434A1 Compounds with growth hormone releasing properties |
| 01/08/1997 | EP0751932A1 Vitamin-d amide derivatives |
| 01/08/1997 | EP0469075B1 Use of lipoxin a 4? and its derivatives as antagonists for slow-reacting substances of anaphylaxis |
| 01/08/1997 | CN1139928A Novel compound |
| 01/08/1997 | CN1139574A Jiushenjian Midicine prescription for acute renal failure and Chronic renal insufficiency |
| 01/07/1997 | US5591761 Thiophenyl-, furyl-and pyrrolyl-sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 01/07/1997 | US5591754 Benzoylguanidines, pharmaceutical composition containing them and treatment of arrthythmias therewith |
| 01/07/1997 | US5591730 Inhibition of urinary calculi growth |
| 01/07/1997 | CA2024381C Xanthine compounds |
| 01/07/1997 | CA2011329C Xanthine derivatives |
| 01/03/1997 | WO1997000079A1 P-selectin ligands and related molecules and methods |
| 01/03/1997 | WO1997000069A1 Melatonin agonists for treating benign prostatic hyperplasia |
| 01/03/1997 | WO1996037201A3 METHODS AND COMPOSITIONS FOR INHIBITING 5α-REDUCTASE ACTIVITY |
| 01/03/1997 | CA2224649A1 Melatonin agonists for treating benign prostatic hyperplasia |
| 01/03/1997 | CA2224625A1 P-selectin ligands and related molecules and methods |
| 01/02/1997 | EP0751149A2 Phenylalanine substitution analogues of magainin peptides |
| 01/02/1997 | EP0751148A2 D-amino acid substitution analogues of Magainin peptides |
| 01/02/1997 | EP0751137A1 Oxaindene derivatives and a process for preparing them as well as medicaments containing them and the use of them |
| 01/02/1997 | EP0751132A1 Pyridazinone derivatives and processes for preparing the same |
| 01/02/1997 | EP0750909A1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence |
| 01/02/1997 | EP0750666A1 HUMAN trk RECEPTORS AND NEUROTROPHIC FACTOR INHIBITORS |
| 01/02/1997 | EP0750614A1 Quinazolinyl-amino derivatives having alpha-antagonist activity |
| 01/02/1997 | EP0750500A1 Treatment of diabetic nephropathy with valsartan |
| 01/01/1997 | CN1139383A Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 12/31/1996 | US5589497 Antiandrogens |
| 12/31/1996 | US5589482 Benzo-thiophene estrogen agonists to treat prostatic hyperplasia |
| 12/31/1996 | US5589190 Sustained-release compositions of alfuzosin hydrochloride |
| 12/28/1996 | CA2180029A1 Oxaindene derivatives and process for the preparation thereof |
| 12/28/1996 | CA2179939A1 Pyridazinone derivatives and processes for preparing the same |
| 12/27/1996 | WO1996041795A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/27/1996 | WO1996041645A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | WO1996041626A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | EP0749964A1 N-Heterocyclyl biphenyl sulfonamides |
| 12/27/1996 | EP0749313A1 Method for treating 5ht 2b receptor related conditions |
| 12/27/1996 | EP0500853B1 Phenylethanolamines, drugs containing these compounds, and a method of preparing them |
| 12/27/1996 | CA2224563A1 Combination of a cyclooxygenase-2 inhibitor and a leukotriene b4 receptor antagonist for the treatment of inflammations |
| 12/27/1996 | CA2224517A1 Compositions comprising a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor |
| 12/27/1996 | CA2223869A1 Benzamide derivatives and their use as vasopressin antagonists |
| 12/25/1996 | CN1138583A 9-substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 12/24/1996 | US5587479 Basic derivatives of glutamic acid and aspartic acid as gastrin or cholecystokinin antagonists |
| 12/24/1996 | US5587377 Terazosin crystalline polymorph and pharmaceutical compositions thereof |
| 12/24/1996 | US5587376 Antiischemic agents, decongestants |
| 12/24/1996 | US5587375 Azepinone compounds useful in the inhibition of ACE and NEP |
| 12/19/1996 | WO1996040737A1 Reversible cysteine protease inhibitors |
| 12/19/1996 | WO1996040681A1 N-heteroaryl-pyridinesulfonamide derivatives and their use as endothelin antagonists |
| 12/19/1996 | WO1996040638A1 Heteroaryl diol acids as leukotriene antagonists |
| 12/19/1996 | WO1996040634A1 Pyrrole derivatives and medicinal composition |
| 12/19/1996 | WO1996040184A1 New cryptophycins from synthesis |
| 12/19/1996 | WO1996040181A1 Processed ginseng having enhanced pharmacological effect |
| 12/19/1996 | WO1996040171A1 Intrauterine chemical necrosing method and composition |
| 12/19/1996 | WO1996040142A1 Heterocyclic ring-fused pyrimidine derivatives |
| 12/19/1996 | WO1996040136A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONIST |
| 12/19/1996 | WO1996040134A1 Calcium channel antagonists |
| 12/19/1996 | WO1996040116A1 Indolinone compounds for the treatment of disease |
| 12/19/1996 | WO1996040085A2 Transdermal compositions containing low molecular weight drugs which are liquid at room temperatures |
| 12/19/1996 | WO1996040078A1 Delivery of drugs to the lower gi tract |
| 12/19/1996 | CA2224170A1 Delivery of drugs to the lower gi tract |
| 12/19/1996 | CA2223711A1 Calcium channel antagonists |
| 12/19/1996 | CA2222972A1 Reversible cysteine protease inhibitors |
| 12/19/1996 | CA2221744A1 Alpha 1a adrenergic receptor antagonists |
| 12/18/1996 | EP0748807A1 Derivatives of N-(1,4-diazabicyclo(2.2.2)-oct-2-yl)methyl benzamide, their preparation and their therapeutical use |
| 12/18/1996 | EP0748800A2 Pyrimidinedione, pyrimidinetrione, triazinedione, tetrahydroquinazolinedione derivatives as alpha-1-adrenergic receptor antagonists |
| 12/18/1996 | EP0748795A2 Substituted benzyloxycarbonyl guanidines as Na+/H+ exchange inhibitors, process for their preparation, their use as medicinal or diagnostic agents as well as medicament containing them |
| 12/18/1996 | EP0748627A2 Melatonin agonists for use in the treatment of benign prostatic hyperplasia |
| 12/18/1996 | EP0748315A1 Use of imidazole derivatives for treating disorders involving angiotensin receptors at 1? and at 2?, certain such products, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing same |
| 12/18/1996 | EP0748314A1 Novel tetrasubstituted imidazole derivatives, method for preparing same, resulting novel intermediates, use thereof as drugs, and pharmaceutical compositions containing same |
| 12/18/1996 | EP0748221A1 7-substituted-4-aza-steroid derivatives as 5-alpha- reductase inhibitors |
| 12/18/1996 | EP0748219A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis |
| 12/18/1996 | EP0690855B1 Benzopyranes as potassium channel openers |
| 12/18/1996 | CN1138029A Fluorophenyl sbstd. alkenylc arboxylic acid-guanidine its preparation method, applied as medicine and diagnosis agent and medicine containing the compound |
| 12/18/1996 | CN1137894A Venlafaxine in treatment of hypothalamic amenorrhea in non-depressed women |
| 12/18/1996 | CN1033580C N-alkyl-3-phenyl-3-(2-alkylthiophenoxy) propylamines |
| 12/17/1996 | US5585394 1-benzenesulfonyl-1,3-dihydro-2H-benzimidazol-2-one derivatives |
| 12/17/1996 | US5585381 Pyrimidine derivatives and pharmaceutical composition |
| 12/17/1996 | US5585374 Anxiolytic agents, antidepressants, cognition activators |
| 12/17/1996 | US5585345 CTP extended form of glycoprotein hormones |
| 12/14/1996 | CA2178849A1 N-[(1,4-diazabicyclo[2.2.2]oct-2-yl)methyl]benzamide derivatives, their preparation and their application in therapeutics |
| 12/12/1996 | WO1996039497A1 Transforming growth factor alpha hi |
| 12/12/1996 | WO1996039439A1 Human g-protein receptor hcegh45 |
| 12/12/1996 | WO1996039372A2 Macrophage lipid chemoattractant |
| 12/12/1996 | WO1996039140A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 12/12/1996 | WO1996034010A3 Inhibitors of farnesyl-protein transferase |
| 12/12/1996 | CA2223957A1 Transforming growth factor alpha hi |
| 12/12/1996 | CA2222040A1 Macrophage lipid chemoattractant |
| 12/12/1996 | CA2221842A1 Alpha 1a adrenergic receptor antagonists |
| 12/12/1996 | CA2221637A1 Human g-protein receptor hcegh45 |
| 12/11/1996 | EP0747395A1 Composition for treating renal failure |
| 12/11/1996 | EP0747392A1 1,2-Diazepine containing dual action inhibitors |
| 12/11/1996 | EP0747380A1 Compounds and compositions with nitrogen-containing non-basic side chains |
| 12/11/1996 | EP0747377A1 Compounds and compositions with nitrogen-containing non-basic side chains |
| 12/11/1996 | EP0747376A1 Compounds and compositions with nitrogen-containing non-basic side chains |
| 12/11/1996 | EP0747354A1 3-Substituted oxindole derivatives as potassium channel modulators |
| 12/11/1996 | EP0746557A1 Intracellular signalling mediators |
| 12/11/1996 | EP0746343A1 METHODS AND COMPOSITIONS OF A BIOARTIFICIAL KIDNEY SUITABLE FOR USE $i(IN VIVO) OR $i(EX VIVO) |
| 12/11/1996 | EP0746332A1 Dna encoding a human neuropeptide y/peptide yy/pancreatic polypeptide receptor (y4) and uses thereof |
| 12/11/1996 | EP0533840B1 Treatment of chronic renal failure with imidazole angiotensin-ii receptor antagonists |